These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 8680026
21. Reduction of bcl-2 in T cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erythematosus. Falcini F, Azzari C, Gelli VA, Luchetti M, Gabrielli A, Calzolari A, Pignone A, Generini S, Matucci Cerinic M. Clin Immunol; 1999 Oct; 93(1):59-64. PubMed ID: 10497011 [Abstract] [Full Text] [Related]
22. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Jais X, Launay D, Yaici A, Le Pavec J, Tchérakian C, Sitbon O, Simonneau G, Humbert M. Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255 [Abstract] [Full Text] [Related]
23. Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity. Robak E, Niewiadomska H, Robak T, Bartkowiak J, Błoński JZ, Woźniacka A, Pomorski L, Sysa-Jedrezejowska A. Mediators Inflamm; 2001 Aug; 10(4):179-89. PubMed ID: 11577994 [Abstract] [Full Text] [Related]
24. Analysis of changes in joint function and peripheral blood mononuclear cells in patients with systemic lupus erythematosus and intervention effects of different drugs. Zhou QS, Hu J, Hu H. Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4423-4430. PubMed ID: 29077150 [Abstract] [Full Text] [Related]
25. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus. Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M. Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961 [Abstract] [Full Text] [Related]
26. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus. Patschan S, Dolff S, Kribben A, Dürig J, Patschan D, Wilde B, Specker C, Philipp T, Witzke O. Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242 [Abstract] [Full Text] [Related]
27. Severe infections in plasmapheresis-treated systemic lupus erythematosus. Aringer M, Smolen JS, Graninger WB. Arthritis Rheum; 1998 Mar; 41(3):414-20. PubMed ID: 9506568 [Abstract] [Full Text] [Related]
28. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF. Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052 [Abstract] [Full Text] [Related]
29. Micronuclei frequency in peripheral blood lymphocytes of thyroid cancer patients after radioiodine therapy and its relationship with metastasis. Joseph LJ, Bhartiya US, Raut YS, Kand P, Hawaldar RW, Nair N. Mutat Res; 2009 Apr 30; 675(1-2):35-40. PubMed ID: 19386245 [Abstract] [Full Text] [Related]
30. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship. Wouters CH, Diegenant C, Ceuppens JL, Degreef H, Stevens EA. Br J Dermatol; 2004 Apr 30; 150(4):693-700. PubMed ID: 15099365 [Abstract] [Full Text] [Related]
31. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Lin SC, Chen KH, Lin CH, Kuo CC, Ling QD, Chan CH. Eur J Clin Invest; 2007 Dec 30; 37(12):987-96. PubMed ID: 18036033 [Abstract] [Full Text] [Related]
32. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. Somers EC, Marder W, Christman GM, Ognenovski V, McCune WJ. Arthritis Rheum; 2005 Sep 30; 52(9):2761-7. PubMed ID: 16142702 [Abstract] [Full Text] [Related]
33. CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids. Azab NA, Bassyouni IH, Emad Y, Abd El-Wahab GA, Hamdy G, Mashahit MA. Clin Immunol; 2008 May 30; 127(2):151-7. PubMed ID: 18299252 [Abstract] [Full Text] [Related]
34. The characteristics of systemic lupus erythematosus. A study in a general hospital. Karadsheh MF, Nimri FA, Ajlouni YM, Dneibat WA, Karadsheh RF. Saudi Med J; 2000 Mar 30; 21(3):282-6. PubMed ID: 11533799 [Abstract] [Full Text] [Related]
35. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, Sanz I. Arthritis Rheum; 2004 Nov 30; 50(11):3580-90. PubMed ID: 15529346 [Abstract] [Full Text] [Related]
36. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production. Kawamoto M, Harigai M, Hara M, Kawaguchi Y, Tezuka K, Tanaka M, Sugiura T, Katsumata Y, Fukasawa C, Ichida H, Higami S, Kamatani N. Arthritis Res Ther; 2006 Nov 30; 8(3):R62. PubMed ID: 16563187 [Abstract] [Full Text] [Related]
37. Bullous systemic lupus erythematosus induced by the therapy for lupus nephritis. Jedlickova H, Bohmová J, Sirotkova A. Int J Dermatol; 2008 Dec 30; 47(12):1315-6. PubMed ID: 19126028 [No Abstract] [Full Text] [Related]
38. Electron microscopic study of distinctive structures in peripheral blood lymphocytes obtained from twins with systemic lupus erythematosus. Imamura M, Block SR, Mellors RC. Am J Pathol; 1975 Dec 30; 81(3):561-74. PubMed ID: 174432 [Abstract] [Full Text] [Related]
39. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study. Dhir V, Singh AP, Aggarwal A, Naik S, Misra R. Lupus; 2009 Aug 30; 18(9):785-91. PubMed ID: 19578102 [Abstract] [Full Text] [Related]
40. Association of mannose binding lectin (MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus. Takahashi R, Tsutsumi A, Ohtani K, Muraki Y, Goto D, Matsumoto I, Wakamiya N, Sumida T. Ann Rheum Dis; 2005 Feb 30; 64(2):311-4. PubMed ID: 15647440 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]